Cas:52286-59-6 Ginsenoside Re manufacturer & supplier

Chemical Name:Ginsenoside Re

CAS.NO:52286-59-6

Synonyms:β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-;chikusetsusaponinivc;Ginsenoside Re;Panaxoside;(2S,3R,4S,5S,6R)-2-({(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-{[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-3,12-dihydroxy-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methyl-5-hepten-2-yl}oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol;(3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside;gingenoside Re;ginsenoside-Re standard;(3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside;ginsenoside-Re;GINSENOSIDE GINSENOSIDE-RE;EINECS 257-814-6;ginsenosideb2;(3β,6α,12β)-6-{[2-O-(6-Deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy}-3,12-dihydroxydammar-24-en-20-yl β-D-glucopyranoside;MFCD00133369;(2S,3R,4S,5S,6R)-2-({(2S)-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-6-{[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxyméthyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-méthyltétrahydro-2H-pyran-2-yl]oxy}tétrahydro-2H-pyran-2-yl]oxy}-3,12-dihydroxy-4,4,8,10,14-pentaméthylhexadécahydro-1H-cyclopenta[a]phénanthrén-17-yl]-6-méthyl-5-heptèn-2-yl}oxy)-6-(hydroxyméthyl)tétrahydro-2H-pyran-3,4,5-triol;β-D-Glucopyranoside, (3β,6α,12β)-6-[[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-3,12-dihydroxydammar-24-en-20-yl

Molecular Formula:C₄₈H₈₂O₁₈

Molecular Weight:947.154

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:1011.8±65.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.611

PSA:298.14000

Exact Mass:946.550110

LogP:4.75

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,β-D-Glucopyranoside, (3β,6α,12β)-6-[[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-3,12-dihydroxydammar-24-en-20-yl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 257-814-6 Use and application,β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)- technical grade,usp/ep/jp grade.

Related News: The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. Ginsenoside Re manufacturer Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings. Ginsenoside Re supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. Ginsenoside Re vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Ginsenoside Re factory Travel alerts: As the Wuhan coronavirus spreads around China, infecting more people, a number of countries have raised their travel advisory warnings.